| ICER Discount Rate (ADA) | ||||
|---|---|---|---|---|
| Mean Cost Differences | 0.29 | 0.31 | 0.33 | |
| ICER Discount | 0.418 | 93 (P = 0.75) | 148 (P = 0.61) | 203 (P = 0.49) |
| Rate (IXE) | 0.44 | −21 (P = 0.94) | 34 (P = 0.91) | 89 (P = 0.76) |
| USD | 0.462 | −135 (P = 0.64) | −80 (P = 0.78) | −25 (P = 0.93) |
| Median Cost Differences | 0.29 | 0.31 | 0.33 | |
| ICER Discount | 0.418 | 351 (P = 0.001) | 406 (P < 0.001) | 466 (P < 0.001) |
| Rate (IXE) | 0.44 | 231 (P = 0.02) | 285 (P = 0.002) | 346 (P < 0.001) |
| USD | 0.462 | 101 (P = 0.43) | 158 (P = 0.11) | 216 (P = 0.02) |
ADA = adalimumab; ICER = Institute for Clinical and Economic Review; IXE = ixekizumab; PsO = psoriasis.